Skip to main content

2 Reasons to Avoid CNS and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CNS Cover Image

Over the past six months, Cohen & Steers has been a great trade, beating the S&P 500 by 25.7%. Its stock price has climbed to $82.27, representing a healthy 34% increase. This performance may have investors wondering how to approach the situation.

Is there a buying opportunity in Cohen & Steers, or does it present a risk to your portfolio? Get the full stock story straight from our expert analysts, it’s free.

Why Is Cohen & Steers Not Exciting?

Despite the momentum, we’re passing on Cohen & Steers for now. Here are two reasons why CNS doesn’t excite us, plus one stock we’d rather own.

1. Long-Term Revenue Growth Disappoints

Examining a company’s long-term performance can provide clues about its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years.

Unfortunately, Cohen & Steers’s 3.2% annualized revenue growth over the last five years was sluggish. This fell short of our benchmark for the financials sector.

Cohen & Steers Quarterly Revenue

2. EPS Growth Has Stalled

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Cohen & Steers’s flat EPS over the last five years was below its 3.2% annualized revenue growth. This tells us the company became less profitable on a per-share basis as it expanded.

Cohen & Steers Trailing 12-Month EPS (Non-GAAP)

Final Judgment

Cohen & Steers isn’t a terrible business, but it doesn’t pass our bar. With its shares beating the market recently, the stock trades at 22.3× forward P/E (or $82.27 per share). This valuation tells us it’s a bit of a market darling with a lot of good news priced in - we think there are better stocks to buy right now. Let us point you toward the most entrenched endpoint security platform on the market.

Stocks We Would Buy Instead of Cohen & Steers

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  284.02
+12.44 (4.58%)
AAPL  303.42
-5.49 (-1.78%)
AMD  484.64
+8.49 (1.78%)
BAC  62.48
+0.53 (0.86%)
GOOG  372.47
+15.82 (4.44%)
META  590.24
+33.53 (6.02%)
MSFT  487.65
+22.93 (4.93%)
NVDA  206.64
+5.89 (2.93%)
ORCL  141.85
+11.98 (9.22%)
TSLA  322.08
+10.87 (3.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.